We are live on ! Find out more
MGNX icon

MacroGenics
MGNX

132 hedge funds and large institutions have $835M invested in MacroGenics in 2016 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 47 increasing their positions, 36 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,075% more call options, than puts

Call options by funds: $2.77M | Put options by funds: $236K

89% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 9

31% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 36

10% more capital invested

Capital invested by funds: $760M → $835M (+$75.2M)

6% more funds holding

Funds holding: 125 → 132 (+7)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
132
Holders Change
+7
Holders Change %
+5.6%
% of All Funds
3.52%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
17
Increased
47
Reduced
36
Closed
9
Calls
$2.77M
Puts
$236K
Net Calls
+$2.54M
Net Calls Change
+$1.81M

Top Buyers

Rank Fund Capital Flow
1
BB
BB Biotech
Switzerland
+$27.8M
2
HRCM
Hood River Capital Management
Florida
+$5.63M
3
AG
Artal Group
Luxembourg
+$4.46M
4
SIM
Spark Investment Management
New York
+$3.71M
5
Millennium Management
Millennium Management
New York
+$3.59M

Top Sellers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$22.1M
2
Federated Hermes
Federated Hermes
Pennsylvania
-$13.1M
3
BI
BVF Inc
California
-$5.4M
4
O
OrbiMed
New York
-$4.03M
5
JP Morgan Chase
JP Morgan Chase
New York
-$3.38M
Name Holding Trade Value Shares
Change 		Change in
Stake
First Eagle Investment Management
26
First Eagle Investment Management
New York
$6.63M – – –
Jennison Associates
27
Jennison Associates
New York
$5.84M -$31.3K -1,051 -0.5%
Millennium Management
28
Millennium Management
New York
$5.7M +$3.59M +120,552 +172%
HRCM
29
Hood River Capital Management
Florida
$5.66M +$5.63M +189,174 New
Balyasny Asset Management
30
Balyasny Asset Management
Illinois
$5.38M +$892K +30,000 +20%
AG
31
Artal Group
Luxembourg
$4.49M +$4.46M +150,000 New
OM
32
Opaleye Management
Massachusetts
$4.34M +$982K +33,000 +29%
RPAM
33
Rhenman & Partners Asset Management
Sweden
$4.19M – – –
Bank of New York Mellon
34
Bank of New York Mellon
New York
$3.93M -$218K -7,314 -5%
SFM
35
Sphera Funds Management
Israel
$3.89M – – –
BIM
36
BlackRock Investment Management
Delaware
$3.74M +$6.28K +211 +0.2%
Charles Schwab
37
Charles Schwab
California
$3.6M +$167K +5,614 +5%
Principal Financial Group
38
Principal Financial Group
Iowa
$3.42M +$29.3K +985 +0.9%
Allianz Asset Management
39
Allianz Asset Management
Germany
$3.37M -$331K -11,122 -9%
CS
40
Candriam SCA
Luxembourg
$3.29M -$1.17M -39,500 -26%
JP Morgan Chase
41
JP Morgan Chase
New York
$3.15M -$3.38M -113,664 -52%
Marshall Wace
42
Marshall Wace
United Kingdom
$2.86M -$795K -26,714 -22%
Arrowstreet Capital
43
Arrowstreet Capital
Massachusetts
$2.83M +$2.81M +94,468 New
BG
44
Bellevue Group
Switzerland
$2.48M – – –
IHM
45
Iguana Healthcare Management
New York
$2.39M +$149K +5,000 +7%
OAM
46
Oxford Asset Management
United Kingdom
$2.28M -$599K -20,129 -21%
PCA
47
Private Capital Advisors
Connecticut
$2.17M +$2.16M +72,500 New
California State Teachers Retirement System (CalSTRS)
48
California State Teachers Retirement System (CalSTRS)
California
$2.02M +$17.8K +600 +0.9%
NI
49
Numeric Investors
Massachusetts
$1.76M +$297K +10,000 +20%
SCM
50
Suffolk Capital Management
New York
$1.64M -$97.9K -3,293 -6%
1
2
3 4 5

MGNX Hedge Fund Activity: Q3 2016 in Review

132 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in MacroGenics (MGNX) for Q3 2016, worth a combined $835M — up 9.9% from $760M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new MGNX positions and 9 closed out — a net gain of 8 holders — while 47 added to existing stakes and 36 trimmed.

The largest buyer was BB Biotech, adding an estimated $27.8M. The largest seller was Point72 Asset Management, cutting an estimated $22.1M.

  • 132 institutional investors held MacroGenics (MGNX) as of Q3 2016, up from 125 in Q2 2016.
  • Funds reported $835M of MacroGenics stock for Q3 2016, up 9.9% quarter-over-quarter.
  • 17 funds opened new MacroGenics positions in Q3 2016 and 9 closed out, a net change of +8 holders.
  • The largest MacroGenics buyer in Q3 2016 was BB Biotech, an estimated $27.8M added.
  • The largest MacroGenics seller in Q3 2016 was Point72 Asset Management, an estimated $22.1M sold.

Based on aggregated 13F filings for Q3 2016.